Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Intracranial Aneurysm Market (2020-2025) by Type, Condition, Treatment Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Intracranial Aneurysm Market is estimated to be USD 1.1 Bn in 2020 and is expected to reach USD 1.78 Bn by 2025, growing at a CAGR of 9.2%.
Key factors such as the growing prevalence of strokes and haemorrhages followed by the increasing incidences of hypertension and artery wall disorders amongst the individuals are the common drivers for the growth of the Intracranial Aneurysm Market. Similarly, the preference for minimally invasive procedures with the availability of medicines and devices is boosting the growth of the market further. Moreover, the increasing healthcare funding by government bodies, the adoption of advanced technologies and novel devices, and the growing research and development activities are creating potential opportunities for the market.
However, factors such as high treatment costs and unrecognized symptoms of the brain aneurysm are likely to restrain the market growth.
The Global Intracranial Aneurysm Market is segmented further based on Type, Condition, Treatment Type, End-User, and Geography.
By Type, the market is classified as Surgical Clipping, Endovascular Coiling, Flow Diverters, and others. Amongst all, the endovascular coiling segment holds the highest market share.
By Condition, the market is classified as an unruptured aneurysm and Ruptured aneurysm. Amongst all, the ruptured aneurysm segment holds the highest market share.
By Treatment Type, the market is classified as Medication and Surgery. Amongst all, the surgery segment holds the highest market share.
By End-user, the market is classified as Hospital & Clinics, Diagnostic Centers, and others. Amongst all, the hospital segment holds the highest market share.
By Geography, North America is projected to lead the market.
1. Stryker Corp has launched its Surpass Evolve flow diverter (a 64-wire cobalt-chromium flow diverter) in the US for redirecting blood flow and handling aneurysm healing. - 24th August 2020
2. Raumedic introduces an intracranial pressure monitoring device - Raumed Home for patients seeking ICP monitoring at home. - 13th November 2019
Some of the companies covered in the report are Raumedic AG, DePuy Synthes, Integra Life Sciences Corporation, Orsan Medical Technologies, B Braun, Medtronic Plc., and Stryker Corp, etc.
The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Why buy this report?
The report offers a comprehensive evaluation of the Global Intracranial Aneurysm Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.
A complete analysis of the market, including parent industry
Important market dynamics and trends
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
Key Topics Covered:
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.4 Years Considered
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
4 Market Overview
4.2 Market Dynamics
22.214.171.124 Growing prevalence of strokes and hemorrhages
126.96.36.199 Increasing incidence of hypertension and arteriosclerosis amongst individuals
188.8.131.52 Increasing demand for minimally invasive procedures
184.108.40.206 High treatment cost
220.127.116.11 Unrecognized symptoms of the brain aneurysm
18.104.22.168 Higher risk of aneurysm recurrence
22.214.171.124 Adoption of advanced technologies and novel devices
126.96.36.199 Increasing healthcare funding by government bodies
188.8.131.52 Rise in research and development activities
184.108.40.206 Commercialization of the products in the developing economies
5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Intracranial Aneurysm Market, By Type
6.2 Surgical Clipping
6.3 Endovascular Coiling
6.4 Flow Diverters
7 Global Intracranial Aneurysm Market, By Condition
7.2 Unruptured Aneurysm
7.3 Ruptured Aneurysm
8 Global Intracranial Aneurysm Market, By Treatment Type
9 Global Intracranial Aneurysm Market, By End User
9.3 Specialty Clinics
10 Global Intracranial Aneurysm Market, by Geography
10.2 North America
10.3 South America
10.4.6 Rest of Europe
10.5.6 South Korea
10.5.9 Rest of APAC
10.6 Rest of the World
10.6.2 Saudi Arabia
10.6.3 South Africa
10.6.4 United Arab Emirates
10.6.5 Latin America
11 Competitive Landscape
11.1 Competitive Quadrant
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Mergers & Acquisitions
11.3.2 Agreement, Collaborations, & Partnerships
11.3.3 New Product Launches & Enhancements
11.3.4 Investments & Funding
12 Company Profiles
12.3 Microport Scientific Corporation
12.4 B. Braun
12.5 Stryker Corp.
12.7 Johnson and Johnson Services
12.8 Microvention Inc. (Terumo Corporation)
12.9 Spiegelberg (SHS Medizintechnik Holding GmbH)
12.10 Codman Neuro (Integra LifeSciences)
12.11 Terumo Corporation
12.12 Mizuho Medical Co, Ltd
12.13 Penumbra, Inc
12.14 KANEKA CORPORATION
12.15 Adeor medical AG
12.16 Evasc Medical Systems Corp
12.17 Orsan Medical Technologies
12.18 Raumedic AG
12.19 DePuy Synthes
For more information about this report visit https://www.researchandmarkets.com/r/l0bs3g
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900